These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7033816)

  • 1. The use of dopamine agonists in the treatment of schizophrenia.
    Corsini GU; Pitzalis GF; Bernardi F; Bocchetta A; Del Zompo M
    Neuropharmacology; 1981 Dec; 20(12B):1309-13. PubMed ID: 7033816
    [No Abstract]   [Full Text] [Related]  

  • 2. Apomorphine's antipsychotic activity.
    Schaffer MH; Davis JM; Tamminga CA
    Arch Gen Psychiatry; 1985 Sep; 42(9):927-8. PubMed ID: 2864035
    [No Abstract]   [Full Text] [Related]  

  • 3. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia.
    al-Semaan Y
    Can J Psychiatry; 1996 Sep; 41(7):484-5. PubMed ID: 8884041
    [No Abstract]   [Full Text] [Related]  

  • 5. Protrptyline in the treatment of chronic schizophrenic patients.
    Arbitman R; Yurtcu A; Lehmann HE; Sterlin C; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):131-5. PubMed ID: 4985491
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical effects of apomorphine in schizophrenia.
    Ferrier IN; Johnstone EC; Crow TJ
    Br J Psychiatry; 1984 Apr; 144():341-8. PubMed ID: 6372924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydergine for schizophrenia.
    Cohen MR; Pary R; Burns R
    J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
    [No Abstract]   [Full Text] [Related]  

  • 9. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients.
    Carter C; Robertson L; Nordahl T; Chaderjian M; Kraft L; O'Shora-Celaya L
    Biol Psychiatry; 1996 Nov; 40(9):930-2. PubMed ID: 8896783
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the partial dopamine agonist terguride on negative symptoms in schizophrenics.
    Olbrich R; Schanz H
    Pharmacopsychiatry; 1988 Nov; 21(6):389-90. PubMed ID: 2907647
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of action of D-penicillamine in chronic schizophrenia.
    Mattke DJ; Adler M
    Dis Nerv Syst; 1971 Jun; 32(6):388-91. PubMed ID: 4936807
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxypertine in the treatment of schizophrenia.
    Alapin B; Golebiewska M
    Act Nerv Super (Praha); 1967 Nov; 9(4):436-9. PubMed ID: 4889080
    [No Abstract]   [Full Text] [Related]  

  • 14. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.
    Vinar O; Formánková M; Taussigová D; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058
    [No Abstract]   [Full Text] [Related]  

  • 15. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 16. SCH-12041 in the treatment of acute schizophrenic patients.
    Ota KY; Kurland AA; Ferro-Diaz P
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):327-32. PubMed ID: 4197257
    [No Abstract]   [Full Text] [Related]  

  • 17. Pimozide in the treatment of chronic schizophrenic patients.
    Chouinard G; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):598-603. PubMed ID: 4989691
    [No Abstract]   [Full Text] [Related]  

  • 18. Apomorphine reduces schizophrenic symptoms.
    Schaffer MH; Tamminga CA; Smith RC; Davis JM
    Psychopharmacol Bull; 1980 Jan; 16(1):55-7. PubMed ID: 6987694
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sex differences in schizophrenia].
    Häfner H; Gattaz WF
    Gynakologe; 1995 Dec; 28(6):426-33. PubMed ID: 8566873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular irregularities in schizophrenia--more than an epiphenomenon?].
    Volz HP; Mackert A
    Nervenarzt; 1991 May; 62(5):298-302. PubMed ID: 1865961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.